General Information |
|
Product |
TIE2 Peptide |
Description |
Antigenic Blocking Peptide Tyrosine-protein kinase receptor Tie-1 isoform 2 |
Verified Applications |
Immunocompetition, Immunodepletion |
Peptide Description |
Synthetic peptide taken within amino acid region 540-590 on human Tyrosine-protein kinase receptor Tie-1 isoform 2 protein. |
|
|
Quantity |
250 µg |
Volume |
100 µl |
Form |
Antigenic Blocking Peptide |
Storage |
-20⁰C for long term storage |
|
|
Competition/Depletion assay |
|
|
|
Uniprot # |
Q02763 |
Overview |
ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate. |
Molecular Function |
Kinase, Receptor, Transferase, Tyrosine-protein kinase |
Subcellular Location |
Integral component of membrane |
Expression |
Detected in umbilical vein endothelial cells. Proteolytic processing gives rise to a soluble extracellular domain that is detected in blood plasma (at protein level). Predominantly expressed in endothelial cells and their progenitors, the angioblasts. Has been directly found in placenta and lung, with a lower level in umbilical vein endothelial cells, brain and kidney. |
Structure |
Belongs to the protein kinase superfamily. Tyr protein kinase family. Contains protein kinase domain. |
Alternative Nomenclature |
Angiopoietin 1 receptor antibody CD202b antibody Endothelial tyrosine kinase antibody Endothelium specific receptor tyrosine kinase 2 antibody Hyk antibody p140 TEK antibody TEK antibody tek tyrosine kinase antibody TIE 2 antibody Tunica interna endothelial cell kinase antibody Tyrosine kinase with Ig and EGF homology domains 2 antibody Tyrosine protein kinase receptor TEK antibody Tyrosine protein kinase receptor TIE 2 antibody Venous malformations multiple cutaneous and mucosal antibody VMCM 1 antibody VMCM antibody |
Protein information supplied by UniProt
Product | Note | Status | Price | |
---|---|---|---|---|
|
TIE2-201Y | |||
|
TIE2-Y-FITC | |||
|
TIE2-Y-BIOTIN | |||
|
PC-TIE2 | |||
Display accessory details |
Select your currency:
(c) FabGennix International Inc.